Low expression of Sp100 in laryngeal cancer: Correlation with cell differentiation

Medical Science Monitor

Volumn 16, Issue 6, 2010, Pages

  Li, Wei ^a   Shang, Chao ^a   Guan, Chao ^a   Zhang, Yong ^a   Sun, Kailai ^a   Fu, Weineng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Clinicopathologic characteristics; Differentiation; Laryngeal carcinoma; Sp100

Indexed keywords

MESSENGER RNA; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN SP100; UNCLASSIFIED DRUG; AUTOANTIGEN; CELL NUCLEUS ANTIGEN; SP100 PROTEIN, HUMAN;

ADULT; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CHI SQUARE TEST; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; APOPTOSIS; BIOSYNTHESIS; GENE EXPRESSION REGULATION; LARYNX TUMOR; METABOLISM; METASTASIS; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANTIGENS, NUCLEAR; APOPTOSIS; AUTOANTIGENS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79952328679     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Jemal A, Siegel R, Ward E et al: Cancer statistics, 2007. CA Cancer J Clin, 2007; 57: 43-66
2. Loyo M, Pai SI: The molecular genetics of laryngeal cancer. Otolaryngol Clin North Am, 2008; 41: 657-672
3. Glazer CA, Chang SS, Ha PK, Califano JA: Applying the molecular biology and epigenetics of head and neck cancer in everyday clinical practice. Oral Oncol, 2008
4. Everett RD, Chelbi-Alix MK: PML and PML nuclear bodies: implications in antiviral defense. Biochimie, 2007; 89: 819-830
5. Szostecki C, Guldner HH, Netter HJ, Will H: Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J Immunol, 1990; 145: 4338-4347
6. Worman HJ, Courvalin JC: Antinuclear antibodies specific for primary biliary cirrhosis. Autoimmun Rev, 2003; 2: 211-217
7. Moller A, Sirma H, Hofmann TG et al: Sp100 is important for the stimulatory effect of homeodomain-interacting protein kinase-2 on p53-dependent gene expression. Oncogene, 2003; 22: 8731-8737
8. Everett RD, Rechter S, Papior P et al: PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J Virol, 2006; 80: 7995-8005
9. Krieghoff E, Milovic-Holm K, Hofmann TG: FLASH meets nuclear bodies: CD95 receptor signals via a nuclear pathway. Cell Cycle, 2007; 6: 771-775
10. Sanchez-Pulido L, Valencia A, Rojas AM: Are promyelocytic leukaemia protein nuclear bodies a scaffold for caspase-2 programmed cell death? Trends Biochem Sci, 2007; 32: 400-406
11. Ling PD, Peng RS, Nakajima A et al: Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100. Embo J, 2005; 24: 3565-3675
12. Fu WN, Shang C, Huang DF, Xu ZM et al: Average-12.9 chromosome imbalances coupling with 15 differential expression genes possibly involved in the carcinogenesis, progression and metastasis of supraglottic laryngeal squamous cell cancer. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2006; 23: 7-11
13. Shang C, Fu WN, Guo Y et al: Study of the SH3-domain GRB2-like 2 gene expression in laryngeal carcinoma. Chin Med J (Engl), 2007; 120: 385-388
14. Everett RD, Murray J, Orr A et al: Herpes simplex virus type 1 genomes are associated with ND10 nuclear substructures in quiescently infected human fibroblasts. J Virol, 2007; 81: 10991-1004
15. Yordy JS, Li R, Sementchenko VI et al: Sp100 expression modulates ETS1 transcriptional activity and inhibits cell invasion. Oncogene, 2004; 23: 6654-6665
16. Yordy JS, Moussa O, Pei H et al: Sp100 inhibits ETS1 activity in primary endothelial cells. Oncogene, 2005; 24: 916-931
17. Milovic-Holm K, Krieghoff E, Jensen K et al: FLASH links the CD95 signaling pathway to the cell nucleus and nuclear bodies. Embo J, 2007; 26: 391-401